MANSC1 activators represent a niche class of chemicals that primarily influence the protein through indirect means, leveraging pathways or processes linked to MANSC1. One of the central cellular processes identified in relation to MANSC1 modulation is calcium signaling, a universal intracellular signal with wide-reaching implications for various cellular functions. For example, compounds like Ionomycin, a potent calcium ionophore, foster an increase in intracellular calcium concentrations. MANSC1's activity or expression is calcium-responsive, then chemicals like Ionomycin play a pivotal role in modulating MANSC1 by altering calcium dynamics. Another noteworthy pathway in the context of MANSC1 modulation is the nitric oxide (NO) signaling pathway. NO, a gaseous signaling molecule, is involved in a myriad of physiological and pathophysiological processes, including neurotransmission, immune defense, and regulation of cell death. Chemicals like SNAP, an NO donor, releases nitric oxide, which can further engage in intracellular signaling events. MANSC1 is operational or modulated within NO-responsive pathways, then SNAP's influence on nitric oxide levels can indirectly shape the functionality or expression of MANSC1.
Furthermore, kinase-driven pathways play a foundational role in cellular signaling and fate determination. The presence of activators like 8-Bromo-cAMP, a cAMP analog, which is capable of activating Protein Kinase A (PKA), underscores the relation of MANSC1 within kinase-controlled cellular events. PKA, once activated, can influence numerous downstream targets through phosphorylation. If MANSC1 operates in such a kinase-modulated context, then activators influencing kinases can indirectly steer its activity or expression. Moreover, the impact of phosphodiesterase, such as Milrinone, is undeniable. By inhibiting phosphodiesterase, Milrinone ensures a sustained elevation of cAMP levels in cells. This continued elevation can set off a chain of intracellular events that may touch upon the realms where MANSC1 is active or modulated. In summary, the chemical activators associated with MANSC1 modulation shed light on cellular events and pathways where MANSC1 may find functional relevance. By understanding the influence of these activators on their primary targets and tracing their impacts on interconnected pathways, we gain insights into possible indirect strategies to modulate the enigmatic protein MANSC1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin stimulates adenylate cyclase, elevating cAMP levels. If MANSC1 operates within any cAMP-responsive pathways, Forskolin's elevation of cAMP can indirectly affect the modulation of MANSC1's activity or function. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX prevents cAMP breakdown by inhibiting phosphodiesterase. Elevated cAMP can signal various intracellular events. If MANSC1 is associated with a cAMP-modulated process, IBMX can indirectly modulate MANSC1 by maintaining heightened cAMP levels. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA stimulates Protein Kinase C (PKC). If MANSC1 has any relation to PKC-modulated processes, PMA's activation of PKC can indirectly modulate the function or activity of MANSC1. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, by inhibiting phosphodiesterase, sustains elevated cAMP levels. MANSC1, if part of a cAMP-influenced pathway, can be indirectly affected by the action of Rolipram. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $109.00 $322.00 | 3 | |
Another phosphodiesterase inhibitor, Cilostazol affects the cAMP pathway. If MANSC1 operates in conjunction with or in response to cAMP-modulated processes, Cilostazol's action can provide indirect modulation of MANSC1. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin serves as a JNK activator. If MANSC1 operates in or alongside JNK-responsive pathways, Anisomycin's activation of JNK can indirectly influence MANSC1. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 prevents NF-κB activation. Should MANSC1 operate within or adjacent to NF-κB pathways, BAY 11-7082's modulation of NF-κB can indirectly affect MANSC1 through altered NF-κB signaling. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases. If MANSC1's modulation is influenced by phosphorylation, Calyculin A's inhibition of protein phosphatase activity can indirectly impact MANSC1. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium Orthovanadate inhibits protein tyrosine phosphatases. If MANSC1 operates within tyrosine phosphorylation-influenced pathways, the action of Sodium Orthovanadate can indirectly affect its activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein serves as a tyrosine kinase inhibitor. If MANSC1 is associated with tyrosine kinase-regulated pathways, Genistein's action can offer indirect modulation of MANSC1. | ||||||